Drug Profile
Research programme: PI3 kinase inhibitors - Kither Biotech
Latest Information Update: 27 Jul 2016
Price :
$50
*
At a glance
- Originator Kither Biotech
- Class Anti-inflammatories
- Mechanism of Action 1 Phosphatidylinositol 3 kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Inflammation
Most Recent Events
- 27 Jul 2016 Investigation in Inflammation in Italy (Topical)